SMC4 is overexpressed in multiple tumor cells, including LGG, hepatocellular carcinoma and breast adenocarcinoma, etc. SMC4 predicts unfavorable outcomes in LGG patients independent of histological subtypes. Here, SMC4 is linked to neoplasm.